subscribeSubscribe
price-trendAsk Us
Impact of Baseline Dyskinesia on Safety and Efficacy of NOURIANZ®

Impact of Baseline Dyskinesia on Safety and Efficacy of NOURIANZ®
PR NEWSWIRE
26 May 2020
Share Share
Kyowa Kirin Announces Marketing Authorisation Application for Istradefylline

Kyowa Kirin Announces Marketing Authorisation Application for Istradefylline
PR NEWSWIRE
06 Jan 2020
Share Share
Kyowa Kirin Announces NOURIANZ™ (Istradefylline) Now Available in the U.S.

Kyowa Kirin Announces NOURIANZ™ (Istradefylline) Now Available in the U.S.
BUSINESSWIRE
14 Oct 2019
Share Share
HiFiBiO`s Kite-backed C round; Kyowa Kirin`s Parkinson`s nod; Relief for Sun

HiFiBiO`s Kite-backed C round; Kyowa Kirin`s Parkinson`s nod; Relief for Sun
Angus Liu FIERCE PHARMA
30 Aug 2019
Share Share
FDA approves new add-on drug to treat Parkinson`s disease

FDA approves new add-on drug to treat Parkinson`s disease
BIOSPECTRUMASIA
29 Aug 2019
Share Share
Kyowa Kirin wins FDA nod for once-rejected Parkinson`s drug

Kyowa Kirin wins FDA nod for once-rejected Parkinson`s drug
Angus Liu FIERCE PHARMA
28 Aug 2019
Share Share
FDA OK`s Kyowa Kirin`s istradefylline for Parkinson`s

FDA OK`s Kyowa Kirin`s istradefylline for Parkinson`s
Douglas W. House SEEKINGALPHA
27 Aug 2019
Share Share
Kyowa Kirin Announces FDA Acceptance Istradefylline (KW-6002) NDA resubmisstion

Kyowa Kirin Announces FDA Acceptance Istradefylline (KW-6002) NDA resubmisstion
BUSINESSWIRE
04 Apr 2019
Share Share
Kyowa advances Parkinson’s program despite being dropped by Lundbeck

Kyowa advances Parkinson’s program despite being dropped by Lundbeck
Nick Paul Taylor FIERCE BIOTECH
20 Aug 2018
Share Share